Description

Hdacs/Mtor Inhibitor 1 CAS NO 2271413-06-8 is a potent, small-molecule dual inhibitor targeting both histone deacetylases (HDACs) and the mechanistic target of rapamycin (mTOR) signaling pathway. This compound is of significant interest for its potential to modulate epigenetic regulation and cellular metabolism simultaneously, offering a unique mechanism of action for research applications. It is primarily utilized by pharmaceutical R&D teams and academic researchers in the fields of oncology, neurology, and metabolic disease studies to investigate novel therapeutic strategies and understand complex cellular pathways.

Application

• Biomedical Research: A key tool compound for studying the crosstalk between epigenetic regulation and nutrient-sensing pathways in cell culture models.
• Oncology Research: Investigation of anti-cancer efficacy and mechanisms in various tumor cell lines, particularly where HDAC and PI3K/Akt/mTOR pathways are dysregulated.
• Neurological Disease Models: Exploration of therapeutic potential in preclinical models of neurodegenerative diseases, where both histone acetylation and mTOR signaling play crucial roles.
• Metabolic Disorder Studies: Research into conditions like diabetes and aging, focusing on the compound's impact on autophagy, insulin signaling, and cellular senescence.
• Chemical Biology: Used as a probe to elucidate the biological functions and downstream effects of concurrent HDAC and mTOR inhibition.
• Preclinical Development: Serves as a lead compound or reference standard in early-stage drug discovery programs for evaluating pharmacokinetics and pharmacodynamics.

Basic Information

Product Name	Hdacs/Mtor Inhibitor 1
CAS No.	2271413-06-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	HDAC/mTOR Inhibitor 1; Dual HDAC and mTOR Inhibitor; mTOR/HDAC Inhibitor 1; 2271413-06-8; HDAC and mTOR pathway inhibitor; Epigenetic and metabolic inhibitor; Research compound 2271413-06-8
EINECS	Contact for details

Quality Control

Our Hdacs/Mtor Inhibitor 1 is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical characterization, including identity confirmation by spectroscopic methods and purity assessment by HPLC. Certificates of Analysis (COA) detailing lot-specific results are available upon request, providing full transparency for your research and development needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under desiccant. This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability. Allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥95%
Water Content (KF)	≤1.0%
Solubility	Soluble in DMSO, DMF; sparingly soluble in aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.